Clinical Trial Update: First-in-man Single-dose and Multiple Dose Study to Evaluate the Safety, Tolerability and Efficacy ofHY-133 [Phase 1]

View source ↗

Summary

A first-in-man Phase 1 study evaluating the safety, tolerability and potential efficacy of HY-133 for Staphylococcus aureus infections, currently recruiting at …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Staphylococcus Aureus Infection

Drugs mentioned

• HY-133

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Staphylococcus Aureus | Phase 1 | Status: RECRUITING